Truist Financial
MRNA icon

Truist Financial’s Moderna MRNA Stock Holding History

Truist Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
+17,885
New +$925K ﹤0.01% 1634
2025
Q1 		– Sell
-4,839
Closed -$201K – 2610
2024
Q4 		$201K Sell
4,839
-6,646
-58% -$318K ﹤0.01% 2393
2024
Q3 		$768K Sell
11,485
-7,172
-38% -$658K ﹤0.01% 1659
2024
Q2 		$2.22M Buy
18,657
+1,275
+7% +$161K ﹤0.01% 1221
2024
Q1 		$1.85M Sell
17,382
-2,332
-12% -$235K ﹤0.01% 1322
2023
Q4 		$1.96M Sell
19,714
-156
-0.8% -$13.1K ﹤0.01% 1268
2023
Q3 		$2.05M Buy
19,870
+11,718
+144% +$1.31M ﹤0.01% 1226
2023
Q2 		$990K Buy
8,152
+926
+13% +$124K ﹤0.01% 1590
2023
Q1 		$1.11M Sell
7,226
-1,591
-18% -$262K ﹤0.01% 1504
2022
Q4 		$1.58M Buy
8,817
+2,225
+34% +$364K ﹤0.01% 1317
2022
Q3 		$779K Buy
6,592
+306
+5% +$46.4K ﹤0.01% 1601
2022
Q2 		$899K Sell
6,286
-802
-11% -$115K ﹤0.01% 1606
2022
Q1 		$1.22M Sell
7,088
-33,285
-82% -$5.6M ﹤0.01% 1528
2021
Q4 		$10.3M Sell
40,373
-3,731
-8% -$1.09M 0.02% 631
2021
Q3 		$17M Sell
44,104
-10,738
-20% -$3.96M 0.03% 461
2021
Q2 		$12.9M Sell
54,842
-8,131
-13% -$1.45M 0.02% 548
2021
Q1 		$8.25M Buy
62,973
+13,934
+28% +$2.02M 0.01% 664
2020
Q4 		$5.12M Buy
49,039
+17,927
+58% +$1.81M 0.01% 804
2020
Q3 		$2.2M Buy
31,112
+26,330
+551% +$1.84M ﹤0.01% 1042
2020
Q2 		$307K Buy
+4,782
New +$262K ﹤0.01% 1937

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Truist Financial's MRNA Position: Q2 2026 in Review

Truist Financial opened a new position in Moderna (MRNA) in Q2 2026: 17,885 shares worth $1.25M. The stake represents ﹤0.01% of the portfolio and ranks #1634 among its holdings. This is a return to the name: Truist Financial previously reported a position in MRNA as recently as Q4 2024.

Truist Financial first reported a position in MRNA in Q2 2020 and has held it in 20 quarters since. The position peaked at $17M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Truist Financial held 17,885 shares of Moderna worth $1.25M as of Q2 2026.
  • Moderna was a new Truist Financial position in Q2 2026.
  • Moderna made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1634 holding.
  • Truist Financial first reported a position in Moderna in Q2 2020 and has held it in 20 quarters since.
  • Truist Financial's Moderna position peaked at $17M in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.